Related Experiment Videos
Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests
European Journal of Pharmacology
|March 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
An outcomes study of an occupational medicine intervention program for the reduction of musculoskeletal disorders and cumulative trauma disorders in the workplace.
Journal of occupational and environmental medicine·1999
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
Journal of affective disorders·1999
Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo.
Psychopharmacology bulletin·1997
A pharmacoeconomic model to evaluate antibiotic costs.
Pharmacotherapy·1994
Fluoxetine impairs clearance of alprazolam but not of clonazepam.
Clinical pharmacology and therapeutics·1992
"Peripheral-type" binding sites for benzodiazepines in brain: relationship to the convulsant actions of Ro 5-4864.
Journal of neurochemistry·1985
Isoginkgetin ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via the SIRT1/NRF2 pathway.
European journal of pharmacology·2026
Morin, a bioflavonoid from a traditional medicinal plant, attenuates inflammasome-associated neuroinflammation in drug-resistant epilepsy.
European journal of pharmacology·2026
Topical Recombinant Human Type III Collagen for Atopic Dermatitis: Evaluation of Efficacy and Safety.
European journal of pharmacology·2026
Pharmacologic Strategies for Anemia in Patient Blood Management: A Systematic Review and Practical Clinical Synthesis.
The Annals of pharmacotherapy·2026
Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.
Prostate cancer and prostatic diseases·2026
Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.
Movement disorders clinical practice·2026
Researchers struggle to improve nonopioid pain drugs.
Science (New York, N.Y.)·2026